Photo by museumsvictoria from unsplash
The new drug not only is a boon for patients with spinal muscular atrophy, but also may spearhead the development of further chemical RNA modulators for a broad range of… Click to show full abstract
The new drug not only is a boon for patients with spinal muscular atrophy, but also may spearhead the development of further chemical RNA modulators for a broad range of conditions.
Keywords:
molecule drug;
small molecule;
rna;
drug;
first small;
drug targeting
Journal Title: Nature Biotechnology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Nature Biotechnology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!